Latest Information Update: 09 Oct 2001
At a glance
- Originator Janssen L.P.
- Class Cardiotonics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute heart failure
Most Recent Events
- 09 Oct 2001 No-Development-Reported for Acute heart failure in Belgium (Unknown route)